What is LOPJLB’s current signal on TARA?

LOPJLB’s latest quantitative signal on Protara Therapeutics, Inc. (TARA) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is TARA in?

Protara Therapeutics, Inc. (TARA) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Protara Therapeutics, Inc. based / listed?

Protara Therapeutics, Inc. is based in US, listed on NASDAQ.

Protara Therapeutics, Inc. (TARA)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.76+4.15%Close

SELLCRISIS · day 12

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $155M
Beta: 1.49
P/E (TTM): -1.88

Short % float: 11.78%
Days to cover: 2.9
SI change: +31.1%

1W: +2.22%
1M: -27.18%

vs SPY 1W: +1.06%
vs SPY 1M: -30.17%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Protara Therapeutics, Inc. is a biotechnology company actively involved in clinical research and development, striving to identify and advance groundbreaking therapies. Their core mission is to tackle significant medical challenges in both oncology and rare disease domains. The…

Employees: 46
Headquarters: US
Founded: 2014
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 56.2M
Float: 87.5%

protaratx.com ↗

Key executives

Jesse Shefferman — Co-founder, Chief Executive Officer, President & Director

Leonardo Viana Nicacio — Chief Medical Officer

Jacqueline Zummo — Co-Founder, Chief R&D Officer

SEC filings

EDGAR · CIK 13599310 · TARA

Analyst consensus

Buy

Bullish6100.0%

Neutral00.0%

Bearish00.0%

L $12.00Avg $12.00H $12.00

Target$12.00+334.78%

Last$2.76

Key stats

Industry peers

Prediction markets

Company news